Pandemic is Best Chance for Big Pharma to Fix Reputation: Brand Expert
September 17, 2020
By Neozene

The following article originally appeared in FiercePharma and was written by Beth Snyder Bulik It’s a once-in-a-generation opportunity for the pharma industry. Reputation and trust are at an all-time high as consumers look to drugmakers for vaccines and treatments that can clear a path out of the COVID-19 pandemic. Don’t break out the champagne just yet, though, warns one branding expert. The door may be open to long-term image repair, but pharma companies have to make real changes, said Interbrand Health Executive Director Barry Silverstein. For too long, the industry has been

Read More

Analysts: Personal Stories Most Likely to Influence People Toward COVID-19 Shots
September 10, 2020
By Neozene

The following article originally appeared in FiercePharma and was written by Beth Snyder Bulik As coronavirus vaccines edge closer to market, the next question is how pharma companies and public health authorities will convince people to get them. Civis Analytics decided to test what kind of messages might work. The data firm created five different themed messages and random tested them with 4,000 respondents. They compared the results to the control group in which 73% said they were likely to get a COVID-19 vaccine. The result? Personal stories proved to be the

Read More

Study Confirms That Steroids Save Very Ill COVID Patients
September 3, 2020
By Neozene

The following article originally appeared in FiercePharma and was written by Angus Liu When researchers in the U.K. said in June that the low-cost corticosteroid dexamethasone could reduce death rates in critically ill COVID-19 patients, clinicians still had doubts about whether to change their treatment practice without full data. But findings from a series of clinical trials from around the world, along with a new meta-analysis—all of which were published on Wednesday in JAMA—will likely change that. The findings “provide definitive data that corticosteroids should be first-line treatment for critically ill patients

Read More